AL
VEA icon

Aspiriant LLC’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Aspiriant LLC’s Portfolio VEA Stock Details VEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4M Buy
241,032
+2,518
+1% +$166K 0.44% 34
2025
Q4 		$14.9M Buy
238,514
+101,044
+74% +$6.19M 0.43% 35
2025
Q3 		$8.24M Buy
137,470
+2,852
+2% +$166K 0.25% 46
2025
Q2 		$7.67M Sell
134,618
-11,137
-8% -$597K 0.24% 48
2025
Q1 		$7.41M Sell
145,755
-3,209
-2% -$162K 0.26% 43
2024
Q4 		$7.12M Buy
148,964
+3,781
+3% +$190K 0.26% 46
2024
Q3 		$7.67M Buy
145,183
+3,136
+2% +$159K 0.29% 42
2024
Q2 		$7.02M Sell
142,047
-1,475
-1% -$73.4K 0.29% 45
2024
Q1 		$7.2M Sell
143,522
-1,016
-0.7% -$49.1K 0.3% 45
2023
Q4 		$6.92M Sell
144,538
-2,875
-2% -$129K 0.31% 44
2023
Q3 		$6.44M Sell
147,413
-747
-0.5% -$34.2K 0.33% 42
2023
Q2 		$6.84M Sell
148,160
-2,565
-2% -$118K 0.35% 41
2023
Q1 		$6.81M Sell
150,725
-6,047
-4% -$269K 0.36% 41
2022
Q4 		$6.58M Buy
156,772
+2,740
+2% +$111K 0.34% 42
2022
Q3 		$5.6M Buy
154,032
+4,336
+3% +$177K 0.27% 44
2022
Q2 		$6.11M Buy
149,696
+32,427
+28% +$1.44M 0.29% 45
2022
Q1 		$5.63M Buy
117,269
+18,874
+19% +$918K 0.31% 46
2021
Q4 		$5.02M Buy
98,395
+2,478
+3% +$127K 0.27% 51
2021
Q3 		$4.84M Sell
95,917
-179
-0.2% -$9.31K 0.28% 44
2021
Q2 		$4.95M Sell
96,096
-1,340
-1% -$69.2K 0.28% 38
2021
Q1 		$4.78M Buy
97,436
+40
+0% +$1.95K 0.31% 35
2020
Q4 		$4.6M Buy
97,396
+256
+0.3% +$11.3K 0.31% 34
2020
Q3 		$3.97M Sell
97,140
-6,023
-6% -$247K 0.31% 39
2020
Q2 		$4M Sell
103,163
-333,042
-76% -$12.2M 0.37% 36
2020
Q1 		$14.6M Sell
436,205
-93,896
-18% -$3.77M 1.43% 16
2019
Q4 		$23.4M Sell
530,101
-6,492
-1% -$277K 2.16% 14
2019
Q3 		$22M Sell
536,593
-53,575
-9% -$2.19M 1.97% 13
2019
Q2 		$24.6M Sell
590,168
-25,564
-4% -$1.05M 2.05% 13
2019
Q1 		$25.2M Sell
615,732
-92,069
-13% -$3.68M 2.06% 14
2018
Q4 		$26.3M Buy
707,801
+49,667
+8% +$1.97M 1.99% 14
2018
Q3 		$28.5M Sell
658,134
-34,561
-5% -$1.49M 2.43% 11
2018
Q2 		$29.7M Sell
692,695
-29,022
-4% -$1.29M 2.54% 10
2018
Q1 		$31.9M Buy
721,717
+630,695
+693% +$28.6M 2.79% 10
2017
Q4 		$4.08M Sell
91,022
-707,276
-89% -$31.2M 1.2% 22
2017
Q3 		$34.7M Sell
798,298
-20,863
-3% -$885K 2.9% 9
2017
Q2 		$33.8M Buy
819,161
+83,356
+11% +$3.4M 2.94% 10
2017
Q1 		$28.9M Buy
735,805
+128,767
+21% +$4.93M 2.46% 11
2016
Q4 		$22.2M Sell
607,038
-160,418
-21% -$5.85M 2.01% 12
2016
Q3 		$28.7M Buy
767,456
+616,482
+408% +$22.7M 2.86% 9
2016
Q2 		$5.88M Sell
150,974
-504,161
-77% -$18.2M 0.56% 26
2016
Q1 		$23.5M Buy
655,135
+628,250
+2,337% +$21.7M 2.24% 11
2015
Q4 		$987K Sell
26,885
-30,030
-53% -$1.13M 0.11% 45
2015
Q3 		$2.16M Buy
56,915
+23,509
+70% +$903K 0.18% 37
2015
Q2 		$1.32M Buy
33,406
+17,464
+110% +$722K 0.13% 39
2015
Q1 		$635K Sell
15,942
-3,236
-17% -$127K 0.08% 53
2014
Q4 		$726K Buy
+19,178
New +$743K 0.1% 48

Other funds holding VEA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Betterment LLC
Betterment LLC New York $52.8B AUM 15.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Aspiriant LLC's VEA Position: Q1 2026 in Review

Aspiriant LLC increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 1.1% in Q1 2026, buying an estimated $166K and bringing the position to 241,032 shares worth $15.4M. The position accounts for 0.44% of the portfolio, ranked #34.

Aspiriant LLC first reported a position in VEA in Q4 2014 and has held it in 46 quarters since. The position peaked at $34.7M in Q3 2017. 2,891 funds tracked by Wall St. Rank hold VEA as of Q1 2026.

  • Aspiriant LLC held 241,032 shares of Vanguard FTSE Developed Markets ETF worth $15.4M as of Q1 2026.
  • Aspiriant LLC bought 2,518 Vanguard FTSE Developed Markets ETF shares in Q1 2026, an estimated $166K.
  • Vanguard FTSE Developed Markets ETF made up 0.44% of Aspiriant LLC's portfolio in Q1 2026, its #34 holding.
  • Aspiriant LLC first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2014 and has held it in 46 quarters since.
  • Aspiriant LLC's Vanguard FTSE Developed Markets ETF position peaked at $34.7M in Q3 2017.
  • 2,891 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.